Tumor vessel compression hinders perfusion of ultrasonographic contrast agents

Neoplasia

Volumn 7, Issue 5, 2005, Pages 528-536

  Galiè, Mirco ^a   D'Onofrio, Mirko ^a   Montani, Maura ^b   Amici, Augusto ^b   Calderan, Laura ^a   Marzola, Pasquina ^a   Benati, Donatella ^a   Merigo, Flavia ^a   Marchini, Cristina ^b   Sbarbati, Andrea ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

CEUS; DCE MRI; Mammary tumor; Transgenic mice; Tumor blood flow

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE ALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; LUNG CAPILLARY; LYMPH FLOW; MICROBUBBLE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

EID: 20344398180     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04730     Document Type: Article

References (35)

1. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, and Schild HH (1999). Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211, 101-110.
2. Brasch RC, Li KC, Husband JE, Keogan MT, Neeman M, Padhani AR, Shames D, and Turetschek K (2000). In vivo monitoring of tumor angiogenesis with MR imaging. Acad Radiol 7, 812-823.
3. Daldrup-Link HE and Brasch RC (2003). Macromolecular contrast agents for MR mammography: current status. Eur Radiol 13, 354-365.
4. Harvey CJ, Blomley MJ, Eckersley RJ, and Cosgrove DO (2001). Development in ultrasound contrast media. Eur Radiol 11, 675-689.
5. Blomley MJ, Cooke JC, Unger EC, Monaghan MJ, and Cosgrove DO (2001). Microbubble contrast agents: a new era in ultrasound. Br Med J 19, 1222-1225.
6. Blomley MJ and Eckersly RJ (2002). Functional ultrasound methods in oncological imaging. Eur J Cancer 38, 2108-2115.
7. Kedar RP, Cosgrove D, McCready VR, Bamber JC, and Carter ER (1996). Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 198, 679-686.
8. D'Onofrio M, Mansueto G, Falconi M, and Procacci C (2004). Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging 29, 246-258.
9. D'Onofrio M, Rozzanigo U, Caffarri S, Zogno A, and Procacci C (2004). Contrast-enhanced US of hepatocellular carcinoma. Radiol Med (Torino) 107, 293-303.
10. Griffon-Etienne G, Boucher Y, Brekken C, Suit HD, and Jain RK (1999). Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res 59, 3776-3782.
11. Sevick EM and Jain RK (1999). Measurement of capillary filtration coefficient in a solid tumor. Cancer Res 51, 1352-1355.
12. Baish JW, Netti PA, and Jain RK (1997). Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. Microvasc Res 53, 128-141.
13. Boucher Y and Jain RK (1992). Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52, 5110-5114.
14. Baxter LT and Jain RK (1989). Transport of fluid and macromolecules in tumors: I. Role of interstitial pressure and convection. Microvasc Res 37, 77-104.
15. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, and Jain RK (2000). Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60, 4324-4327.
16. Carmeliet P and Jain RK (2000). Angiogenesis in cancer and other diseases. Nature 407, 257-259.
17. Sl-Nafussi A (1999). Spindle cell tumours of the breast: practical approach to diagnosis. Histopathology 35, 1-3.
18. Foschini MP, Dina RE, and Eusebi V (1993). Sarcomatoid neoplasms of the breast: proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Semin Diagn Pathol 10, 128-136.
19. Ostrowski JL, Horgan K, Krausz T, and Quinn CM (1998). Monophasic sarcomatoid carcinoma of the breast. Histopathology 32, 184-186.
20. Fisher C (2004). Myofibrosarcoma. Virchows Arch 445, 215-223.
21. Rønnov-Jessen L, Petersen OW, and Bissel MJ (1996). Cellular changes involved in conversion of normal to malignant breast: the importance of the stromal reaction. Physiol Rev 76, 69-125.
22. Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Ronnov-Jessen L, and Bissel MJ (2001). The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 3, 213-217.
23. De Wever O and Mareel M (2003). Role of tissue stroma in cancer cell invasion. J Pathol 200, 429-447.
24. Thiery JP (2002). Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2, 442-454.
25. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, and Brasch RC (1998). Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Pediatr Radiol 26, 67-78.
26. Haase A, Matthaei D, Bartkowski R, Duhmke E, and Leibfritz D (1989). Inversion recovery snapshot FLASH MR imaging. J Comput Assist Tomogr 13, 1036-1040.
27. Galiè M, D'Onofrio M, Calderan L, Nicolato E, Amici A, Crescimanno C, Marzola P, and Sbarbati A (2004). In vivo mapping of spontaneous mammary tumors in transgenic mice using MRI and ultrasonography. J Magn Res Imaging 19, 570-579.
28. Marzola P, Farace P, Calderan L, Crescimanno C, Lunati E, Nicolato E, Benati D, Degrassi A, Terron A, Klapwijk J, et al. (2003). In vivo mapping of fractional plasma volume (fPV) and endothelial transfer coefficient (kPS) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure. Int J Cancer 104, 462-468.
29. Netti PA, Roberge S, Boucher Y, Baxter LT, and Jain RK (1996). Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. Microvasc Res 52, 27-46.
30. Hobson B and Denekamp J (1984). Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer 49, 405-413.
31. Denekamp J and Hobson B (1982). Endothelial-cell proliferation in experimental tumors. Br J Cancer 46, 711-720.
32. Rak JW, St Croix BD, and Kerbel RS (1995). Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 6, 3-18.
33. Kinouchi M, Mano M, Matsuoka I, Kodama S, Aoki T, Okamoto M, Yamamura H, Usami M, and Takahashi K (2003). Immature tumor angiogenesis in high-grade and high-stage renal cell carcinoma. Urology 62, 765-770.
34. Less JR, Skalak TC, Sevick EM, and Jain RK (1991). Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimension. Cancer Res 51, 265-273.
35. Thiery JP (2002). Epithelial-mesenchymal transition in tumor progression. Nat Rev Cancer 2, 442-454.